Display Settings:

Format

Send to:

Choose Destination

    Beilstein J Org Chem. 2008 Jan 21;4:7.

    Unexpected degradation of the bisphosphonate P-C-P bridge under mild conditions.

    Turhanen PA, Vepsäläinen JJ.

    University of Kuopio, Department of Biosciences, Laboratory of Chemistry, PO Box 1627, FIN-70211, Kuopio, Finland. petri.turhanen@uku.fi.

    ABSTRACT: Unexpected degradation of the P-C-P bridge from novel bisphosphonate derivative 1a and known etidronate trimethyl ester (1b) has been observed under mild reaction conditions. A proposed reaction mechanism for the unexpected degradation of 1a and 1b is also reported.

    PMID: 18208588 [PubMed - in process]

    PMCID: 2238746

    Supplemental Content

    Click here to read

    Patient drug information

    • Etidronate (Didronel®)

      Etidronate is used to treat Paget's disease of bone (a condition in which the bones are soft and weak and may be deformed, painful, or easily broken) and to prevent and treat heterotopic ossification (growth of bone tiss...